IPO registrations (S-1, F-1) · Registrants
GENAISSANCE PHARMACEUTICALS INC
- SEC CIK
- 1110009 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-04-20, last 2000-07-31; 1 initial registration, 4 amendments
- Outcome
- Final prospectus filed 2000-08-02
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- DE
- Business address
- FIVE SCIENCE PARK, New Haven, CT 06511
- EIN
- 06-1338846
- EDGAR entity type
- operating
Offering terms
- Proposed price range
- $11.00–$13.00 per share (S-1/A filed 2000-07-31)
- Final price
- $13.00 per share, within the range (424B4 filed 2000-08-02, an initial public offering)
- Shares sold
- 6,000,000
- Gross proceeds
- $78,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol GNSC
- Lead underwriters
- Deutsche Bank
- Syndicate
- Bear Stearns; Citigroup; UBS
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: COGENICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Lobbying client: GENAISSANCE PHARMACEUTICALS Fuzzy (name and state)
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-04-20 | S-1 | S-1 (registration) | GENAISSANCE PHARMACEUTICALS INC | 0000912057-00-019052 ↗ |
| 2000-07-03 | S-1/A | S-1/A (amendment) | GENAISSANCE PHARMACEUTICALS INC | 0000912057-00-030756 ↗ |
| 2000-07-12 | S-1/A | S-1/A (amendment) | GENAISSANCE PHARMACEUTICALS INC | 0000912057-00-031687 ↗ |
| 2000-07-28 | S-1/A | S-1/A (amendment) | GENAISSANCE PHARMACEUTICALS INC | 0000912057-00-033655 ↗ |
| 2000-07-31 | S-1/A | S-1/A (amendment) | GENAISSANCE PHARMACEUTICALS INC | 0000912057-00-033775 ↗ |
| 2000-08-02 | 424B4 | 424B4 (final prospectus) | GENAISSANCE PHARMACEUTICALS INC | 0000912057-00-034185 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-07-31 | S-1/A | registration statement | $11.00–$13.00 | 6,000,000 | - | Nasdaq GNSC | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2000-08-02 | 424B4 | final prospectus | $13.00 | 6,000,000 | $78,000,000 | Nasdaq GNSC | 4 | primary document; price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | COGENICS, INC. | CT | State business registries | EIN (EXACT, as the state registration reports it) |
| Lobbying client | GENAISSANCE PHARMACEUTICALS | CT | Federal lobbying (LDA) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, CT first:
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- DGI RESOLUTION INC K6
- PRA INTERNATIONAL INC VA
- QUEST DIAGNOSTICS INVESTMENTS INC NJ
- SIGNAL PHARMACEUTICALS INC CA
- CURAGEN CORP MA
- DELTAGEN INC CA
- BIORELIANCE CORP MD
- KENDLE INTERNATIONAL INC OH
In other datasets, the same topic (Medical research) in CT:
- Form D issuer: AbbraTech Holdings LLC (Form D private offerings)
- Nonprofit: ACCESSITAS INC (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research